{"id":1067880,"date":"2020-11-19T05:11:45","date_gmt":"2020-11-19T10:11:45","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/a-review-article-defines-lidds-as-a-key-player-in-tlr9-agonist-research-field-and-being-the-only-provider-having-a-sustained-release-product-in\/"},"modified":"2024-08-18T11:40:29","modified_gmt":"2024-08-18T15:40:29","slug":"a-review-article-defines-lidds-as-a-key-player-in-tlr9-agonist-research-field-and-being-the-only-provider-having-a-sustained-release-product-in","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/a-review-article-defines-lidds-as-a-key-player-in-tlr9-agonist-research-field-and-being-the-only-provider-having-a-sustained-release-product-in.php","title":{"rendered":"A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in&#8230;"},"content":{"rendered":"<p><![CDATA[A scientific review article \u201cToll-Like Receptor 9 Agonists in Cancer\u201d, written by Dr Davar Diwakar et al, a prominent immune-oncology research group in Pittsburgh (US), was recently published in the \u00a0OncoTargets and Therapy journal discussing and reviewing key players in preclinical studies and ongoing clinical trials of TLR9 agonists. TLR9 is one of the most promising targets for increasing the response and reversing the resistance to current cancer immunotherapies.]]><\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/18\/2129323\/0\/en\/A-review-article-defines-LIDDS-as-a-key-player-in-TLR9-agonist-research-field-and-being-the-only-provider-having-a-sustained-release-product-in-development.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in...\">A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in...<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original here: A review article defines LIDDS as a key player in TLR9 agonist research field and being the only provider having a sustained release product in... <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/a-review-article-defines-lidds-as-a-key-player-in-tlr9-agonist-research-field-and-being-the-only-provider-having-a-sustained-release-product-in.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1067880","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067880"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1067880"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1067880\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1067880"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1067880"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1067880"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}